Skip to content
Methodology
All entries for: Sartar Therapeutics Oy
July 22, 2025
Sartar Therapeutics Oy
Orphan Drug Designation
FDA orphan drug designation: treatment of soft tissue sarcomas
Disease Area:
Rare Diseases
Source
Scroll to Top